Active	Status	Sponsor type	Region	Phase	Filter
9 Active 10 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Panzuto, Francesco
NCT04282083: Protocol ITANET - Registry	Recruiting	N/A	3600	Europe		Italian Association Neuroendocrine Tumors	Gastro-entero Pancreatic Neuroendocrine Tumors	07/27	07/32
Arvat, Emanuela
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer	Active, not recruiting	3	291	Europe, Canada, Japan, US, RoW	Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib	Loxo Oncology, Inc., Eli Lilly and Company	Medullary Thyroid Cancer	05/23	02/26
NCT06645951: Institution of an Italian Multicenter Database of Patients With Parathyroid Carcinoma or Atypical Parathyroid Adenoma	Not yet recruiting	N/A	300	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Parathyroid Gland Carcinoma, Parathyroid Gland Atypical Adenoma	11/34	11/34
NCT06645899: Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism	Not yet recruiting	N/A	600	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Hypoparathyroidism, Pseudo Hypoparathyroidism	11/34	11/34
ITCO, NCT04031339: Study of Clinical Outcomes of Thyroid Cancer	Recruiting	N/A	15000	Europe	Standard treatment	University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart	Thyroid Neoplasms	01/25	01/25
NCT04282083: Protocol ITANET - Registry	Recruiting	N/A	3600	Europe		Italian Association Neuroendocrine Tumors	Gastro-entero Pancreatic Neuroendocrine Tumors	07/27	07/32
Fonio, Paolo
BIOPEARL-ONE, NCT05911633: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)	Suspended	N/A	50	Europe	BioPearl™	Terumo Europe N.V.	Hepatocellular Carcinoma Non-resectable	06/26	11/27
Grosso, Marco
MioPain, NCT05204667 / 2021-000067-68: Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. Study	Terminated	4	172	Europe	380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily, Robaxisal compuesto, 380 mg/300 mg comprimidos metocarbamol/paracetamol - 6 times daily	Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research	Low Back Pain	11/23	02/24
Calandri, Marco
DEDICATE, NCT06325371: Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2	Recruiting	N/A	100	Europe	Visceral aneurysm stenting, stent	University of Turin, Italy	Aneurysm Abdominal, Arterial Aneurysm	06/25	06/26
Ferraris, Andrea
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Panzuto, Francesco
NCT04282083: Protocol ITANET - Registry	Recruiting	N/A	3600	Europe		Italian Association Neuroendocrine Tumors	Gastro-entero Pancreatic Neuroendocrine Tumors	07/27	07/32
Arvat, Emanuela
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer	Active, not recruiting	3	291	Europe, Canada, Japan, US, RoW	Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib	Loxo Oncology, Inc., Eli Lilly and Company	Medullary Thyroid Cancer	05/23	02/26
NCT06645951: Institution of an Italian Multicenter Database of Patients With Parathyroid Carcinoma or Atypical Parathyroid Adenoma	Not yet recruiting	N/A	300	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Parathyroid Gland Carcinoma, Parathyroid Gland Atypical Adenoma	11/34	11/34
NCT06645899: Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism	Not yet recruiting	N/A	600	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Hypoparathyroidism, Pseudo Hypoparathyroidism	11/34	11/34
ITCO, NCT04031339: Study of Clinical Outcomes of Thyroid Cancer	Recruiting	N/A	15000	Europe	Standard treatment	University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart	Thyroid Neoplasms	01/25	01/25
NCT04282083: Protocol ITANET - Registry	Recruiting	N/A	3600	Europe		Italian Association Neuroendocrine Tumors	Gastro-entero Pancreatic Neuroendocrine Tumors	07/27	07/32
Fonio, Paolo
BIOPEARL-ONE, NCT05911633: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)	Suspended	N/A	50	Europe	BioPearl™	Terumo Europe N.V.	Hepatocellular Carcinoma Non-resectable	06/26	11/27
Grosso, Marco
MioPain, NCT05204667 / 2021-000067-68: Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. Study	Terminated	4	172	Europe	380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily, Robaxisal compuesto, 380 mg/300 mg comprimidos metocarbamol/paracetamol - 6 times daily	Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research	Low Back Pain	11/23	02/24
Calandri, Marco
DEDICATE, NCT06325371: Italian Multicentric Study on the Treatment of Visceral Aneurysms With the Flow Diversion Stent Derivo Peripher and Derivo 2	Recruiting	N/A	100	Europe	Visceral aneurysm stenting, stent	University of Turin, Italy	Aneurysm Abdominal, Arterial Aneurysm	06/25	06/26
Ferraris, Andrea
No trials found